Message below is a paid advertisement. Content is provided by the sponsor.
 
A SPECIAL
ANNOUNCEMENT FROM:
  PT Logo  
If you are having trouble reading this email, read the online version.

header header
Creating a Single Partner for
Your Most Complex Biologics Challenges

Catalent has announced that it agreed to acquire Cook Pharmica, an Indiana-based integrated provider of drug substance and drug product manufacturing and related services, creating a new leader in biologics development, analytical and finished product supply that can provide a single partner from cell line development through commercialization of biologics in vials, prefilled syringes and cartridges.

Integrated Solution from Development to Fill/Finish

With complementary development and supply capabilities for both clinical and small scale commercial production, Catalent Biologics will offer a comprehensive portfolio of integrated solutions to help biotech innovators deliver better treatments to patients, faster.

Advanced Technologies for Better Treatments:

  • GPEx® Cell Line Engineering
  • SMARTag® ADCs & Bioconjugates
  • Advasept® Glass- Free Delivery

 

Integrated Solutions for Faster to Clinic for Biologics & Biosimilars:

  • Cell Line Development
  • Process development
  • Sterile Formulation
  • Flexible Biomanufacturing – Clinical & Commercial
  • Biologics Analytical Services
  • Fill/Finish - vials, prefilled syringes, cartridges, auto-injectors
  • Clinical Supply Services & Solutions

 

Learn More

The combined organization offers a 

global biologics site network with substantial footprint in the US

 


Join an Expert Webinar:
Moving A Complex Protein From Development To Large-Scale Clinical Production

Date: October 11, 2017
Time: 2:00pm ET / 11:00am PT

Attend this webinar to hear from experts on how to overcome challenges when developing a robust upstream cell culture process and scaling to large scale manufacturing. Register Now.

 

 

Presenters:

David Rabuka, PhD

Global Head of R&D, Chemical Biology
Catalent Biologics

 

 

Gregory T. Bleck, PhD
Global Head of R&D, Biologics
Catalent Biologics

Featured eBook: Complex Protein Production

Download the eBook to learn about innovative products and techniques for scale-up of complex biologics, get optimal cell culture medium and feed to maximize performance potential, novel analytical techniques for monoclonal antibodies and cell-line development and process scale-up for an antibody program in which the antibody requires additional processing by a site-specific enzyme for correct functionality.

Speak to Catalent Biologics Experts at CPhI Worldwide

Date: October 24 - 26, 2017

Location: Frankfurt, Germany

Booth: 41G10

line-divider
line-divider
Every molecule has a challenge. We have a solution.
Challenge Us
or call +1 877 891 9609 to speak with one of our experts today!
Follow us on Twitter   Join us on Linkedin   Like us on Facebook   Watch our your YouTube Channel   Videos on Vimeo   Google+ Jobs
For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at sales@catalent.com, or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers.

Catalent Pharma Solutions respects your privacy.

Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement or the website, its owner(s) or the content.
© 2017, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved.
You received this email because you are a customer of PHTE, a UBM publication. You are on the mailing list as %%emailaddress%%.